Prognostic value of tumour budding in oesophageal cancer: A meta-analysis

Histopathology

Volumn 68, Issue 2, 2016, Pages 173-182

  Almangush, Alhadi ^a,b   Karhunen, Markku ^c   Hautaniemi, Sampsa ^c   Salo, Tuula ^c,d,e,f   Leivo, Ilmo ^g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Misurata University   (Libyan Arab Jamahiriya)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e OULU UNIVERSITY HOSPITAL   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY OF TURKU   (Finland)

Author keywords

Oesophageal cancer; Prognostic factor; Tumour budding

Indexed keywords

CANCER GRADING; CANCER PROGNOSIS; DISEASE MARKER; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; META ANALYSIS; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR BUDDING; TUMOR GROWTH; ESOPHAGUS TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ESOPHAGEAL NEOPLASMS; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 84955171957     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12781     Document Type: Review

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127; 2893-2917.
2. Roh MS, Lee JI, Choi PJ. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis. Esophagus 2004; 17; 333-337.
3. Teramoto H, Koike M, Tanaka C et al. Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagus. J. Surg. Oncol. 2013; 108; 42-46.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61; 69-90.
5. Espey DK, Wu XC, Swan J et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 2007; 110; 2119-2152.
6. Umar SB, Fleischer DE. Esophageal cancer: epidemiology, pathogenesis and prevention. Gastroenterol. Hepatol. 2008; 5; 517-526.
7. Mitrovic B, Schaeffer DF, Riddell RH, Kirsch R. Tumor budding in colorectal carcinoma: time to take notice. Mod. Pathol. 2012; 25; 1315-1325.
8. Almangush A, Salo T, Hagstrom J, Leivo I. Tumour budding in head and neck squamous cell carcinoma-a systematic review. Histopathology 2014; 65; 587-594.
9. Liang F, Cao W, Wang Y, Li L, Zhang G, Wang Z. The prognostic value of tumor budding in invasive breast cancer. Pathol. Res. Pract. 2013; 209; 269-275.
10. Miyata H, Yoshioka A, Yamasaki M et al. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 2009; 115; 3324-3334.
11. Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod. Pathol. 2014; 27; 1578-1589.
12. Compton C. Prognostic factors in cancer. 3rd ed. New York: Wiley-Liss, 2006.
13. Koelzer VH, Langer R, Zlobec I, Lugli A. Tumor budding in upper gastrointestinal carcinomas. Front Oncol. 2014; 4; 216.
14. Niwa Y, Yamada S, Koike M et al. Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinoma. J. Surg. Oncol. 2014; 110; 764-769.
15. Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 2010; 1; 651-661.
16. Karamitopoulou E. Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link? Front Oncol. 2013; 3; 221.
17. Nakagawa Y, Ohira M, Kubo N et al. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma. Anticancer Res. 2013; 33; 5023-5029.
18. Yamaguchi Y, Ishii G, Kojima M et al. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness. J. Thorac. Oncol. 2010; 5; 1361-1368.
19. Wang LM, Kevans D, Mulcahy H et al. Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer. Am. J. Surg. Pathol. 2009; 33; 134-141.
20. Brown M, Sillah K, Griffiths EA et al. Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers. Histopathology 2010; 56; 893-899.
21. Wang C, Huang H, Huang Z et al. Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J. Oral Pathol. Med. 2011; 40; 545-551.
22. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 2010; 36; 1-48.
23. Koike M, Kodera Y, Itoh Y et al. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann. Surg. Oncol. 2008; 15; 1977-1982.
24. Ito E, Ozawa S, Kijima H et al. New invasive patterns as a prognostic factor for superficial esophageal cancer. J. Gastroenterol. 2012; 47; 1279-1289.
25. Nakanishi Y, Ohara M, Doumen H, Kimura N, Ishidate T, Kondo S. Correlation between tumor budding and post-resection prognosis in patients with invasive squamous cell carcinoma of the thoracic esophagus. World J. Surg. 2011; 35; 349-356.
26. Mitobe J, Ikegami M, Urashima M, Takahashi H, Goda K, Tajiri H. Clinicopathological investigation of lymph node metastasis predictors in superficial esophageal squamous cell carcinoma with a focus on evaluation of lympho-vascular invasion. Scand. J. Gastroenterol. 2013; 48; 1173-1182.
27. Hammoud GM, Hammad H, Ibdah JA. Endoscopic assessment and management of early esophageal adenocarcinoma. World J. Gastrointest. Oncol. 2014; 6; 275-288.
28. Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin. Cell Dev. Biol. 2010; 21; 19-25.
29. Rogers AC, Gibbons D, Hanly AM et al. Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy. Mod. Pathol. 2014; 27; 156-162.
30. Dikken JL, Coit DG, Klimstra DS et al. Prospective impact of tumor grade assessment in biopsies on tumor stage and prognostic grouping in gastroesophageal adenocarcinoma: relevance of the seventh edition American Joint Committee on Cancer Staging Manual revision. Cancer 2012; 118; 349-357.
31. Wada H, Shiozawa M, Katayama K et al. Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J. Gastroenterol. 2015; 50; 727-734.
32. Lugli A, Karamitopoulou E, Zlobec I. Tumour budding: a promising parameter in colorectal cancer. Br. J. Cancer 2012; 106; 1713-1717.
33. Karamitopoulou E, Zlobec I, Born D et al. Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur. J. Cancer 2013; 49; 1032-1039.
34. Christofori G. New signals from the invasive front. Nature 2006; 441; 444-450.
35. Zlobec I, Lugli A. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J. Gastroenterol. 2009; 15; 5898-5906.
36. Zlobec I, Hadrich M, Dawson H et al. Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients. Br. J. Cancer 2014; 110; 1008-1013.
37. Lugli A, Vlajnic T, Giger O et al. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients. Hum. Pathol. 2011; 42; 1833-1840.
38. Ueno H, Mochizuki H, Hashiguchi Y et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004; 127; 385-394.
39. Horcic M, Koelzer VH, Karamitopoulou E et al. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer. Hum. Pathol. 2013; 44; 697-705.
40. Koelzer VH, Zlobec I, Berger MD et al. Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study. Virchows Arch. 2015; 466; 485-493.
41. Puppa G, Senore C, Sheahan K et al. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy. Histopathology 2012; 61; 562-575.
42. Ohtsuki K, Koyama F, Tamura T et al. Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma. Anticancer Res. 2008; 28; 1831-1836.
43. Morodomi T, Isomoto H, Shirouzu K, Kakegawa K, Irie K, Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989; 63; 539-543.
44. Kanazawa H, Mitomi H, Nishiyama Y et al. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis. 2008; 10; 41-47.